Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Nieland

Carl Nieland, Lexington, KY US

Patent application numberDescriptionPublished
20090274504Modular RFID Imaging Device Option - A device, method, system and article for controlling an image forming device including removable RFID functionality. A print job may be received and a determination may be made as to whether the print job includes RFID data. The RFID data may be sent to a removable RFID module when RFID data is included in the print job. Media may then be provided to a first paper path defined in the removable RFID module when RFID data is included in the print job and provided to a second paper path defined in the image forming device. An image may then be formed on the media.11-05-2009

Carsten Nieland, Gotha DE

Patent application numberDescriptionPublished
20110062236RFID electronic label - A magnetic-guiding laminate is used to improve wireless communication between a transmitter and a receptor disposed on a substrate, regardless of the substrate materials. The laminate can comprise one or more layers of magnetic or non-magnetic material with different magnetic property. For example, the laminate can comprise a paramagnetic layer disposed on a diamagnetic layer, where the paramagnetic layer attracts the magnetic field toward the RFID antenna, and the diamagnetic layer prevents the magnetic field from dispersing in the substrate. Alternatively, the laminate can comprise multiple paramagnetic layers, wherein at least two layers have different magnetic properties, such as different permeability values.03-17-2011

Jan-Harm Nieland, Nijmegen NL

Patent application numberDescriptionPublished
20090045460 MOSFET FOR HIGH VOLTAGE APPLICATIONS AND A METHOD OF FABRICATING SAME - A PMOS device comprises a semiconductor-on-insulator (SOI) substrate having a layer of insulating material over which is provided an active layer of n-type semiconductor material.02-19-2009

John Nieland, Aarhus DK

Patent application numberDescriptionPublished
20100203083MUTATED STRUCTURAL PROTEIN OF A PARVOVIRUS - The present invention is related to a structural protein of a parvovirus with an amino acid insertion at the insertion site I-453, a library comprising the protein, a multimeric structure comprising the protein, a nucleic acid encoding the protein, a vector, virus or cell comprising the nucleic acid, a process for the preparation of the protein, a medicament comprising the protein, nucleic acid or multimeric structure as well as methods and uses involving the protein, nucleic acid or multimeric structure.08-12-2010
20100297177MUTATED PARVOVIRUS STRUCTURAL PROTEINS AS VACCINES - The present invention is related to a method for identifying a parvovirus mutated structural protein capable of specifically binding to a binder for an antigen, a parvovirus mutated structural protein which comprises at least one B-cell epitope heterologous to the parvovirus, a multimeric structure comprising the protein, a nucleic acid encoding the protein, a virus or cell comprising the protein, a method of preparing the protein, a medicament comprising the protein, nucleic acid or multimeric structure and its use.11-25-2010

John Nieland, Arhus C DK

Patent application numberDescriptionPublished
20090143276Trimeric IL-1Ra - Interleuekin-1 receptor antagonists (IL-1Ra) including fusion proteins having a trimerizing domain and an IL-1Ra polypeptide sequence. The fusion proteins are part of trimeric complexes that are used in pharmaceutical compositions for treating diseases mediated by IL-1. Effective treatment of inflammatory diseases, such as rheumatoid arthritis and diabetes, are described.06-04-2009
20100028995Tetranectin Trimerizing Polypeptides - Tetranectin trimerizing polypeptides and fusion proteins including the polypeptides and therapeutic polypeptides and proteins. Trimeric complexes of the polypeptides and fusion proteins. Pharmaceutical compositions of the polypeptides, fusion proteins and the trimeric complexes.02-04-2010

Josephus Dirk Nieland, Aarhus C DK

Patent application numberDescriptionPublished
20110178172Inhibitors of Carnitin-Palmitoyl-Tranferase-1 for the Treatment and prevention of disorders caused by delipidation of neural tissue - Carnitin-Palmitoyl-Transferase-1 (CPT-1) inhibitor for use in treating and/or preventing disorders caused by delipidation of neural tissue.07-21-2011

Josephus Dirk Nieland, Arhus C DK

Patent application numberDescriptionPublished
20110028403HSP70-Based Treatment for Autoimmune Diseases and Cancer - A non-natural HSP70 activating region that activates dendritic cells. Polypeptides that bind to the HSP70 activating region can be used to treat autoimmune diseases, such as vitiligo, by binding to HSP70 and preventing HSP70 form activating dendritic cells. The HSP70 binders can be constructed in the form of fusions proteins with a trimerizing structural element that may associate to form a trimeric complex. Pharmaceutical compositions and methods for treating vitiligo using the HSP70 binding proteins, fusion proteins and complexes.02-03-2011

Josephus Dirk Nieland, Aarhus DK

Patent application numberDescriptionPublished
20090155843TNF ANTAGONISTS - TNF binding polypeptides based on human tetranectin C-type lectin like domains (CTLD) with improved binding characteristics and improved efficacy. The polypeptides comprise a TNF binding domain having the amino acid sequence KRWS-RYF (SEQ ID NO:1). Also provided are methods of preparing the polypeptides of the invention. The polypeptides may be used for the preparation of pharmaceutical compositions, and for treatment of a subject having a pathology mediated by TNF, such as treatment of rheumatoid arthritis.06-18-2009

Sabine Nieland, Gotha DE

Patent application numberDescriptionPublished
20090085226METHOD AND ARRANGEMENT FOR CONTACT-CONNECTING SEMICONDUCTOR CHIPS ON A METALLIC SUBSTRATE - The method comprises the following steps: the substrate in the form of a one-piece basic substrate (04-02-2009

Susanne Nieland, Schipkau DE

Patent application numberDescriptionPublished
20100075395MICROBIAL PROCESS FOR PRODUCTION OF ENZYMES - The present invention relates to a suspension culture process for producing an enzyme, comprising the steps of providing a minimal medium, which contains deionised water, mineral salts and an organic carbon source, in a vessel; inoculating the minimal medium with a fungus; incubating the minimal medium at a pH value of 1-4 for a period of time which is sufficient for the fungus to be optically visible in the minimal medium, and obtaining the enzyme, wherein the minimal medium and the vessel are not sterilised. In addition, the invention relates to an enzyme obtainable by the process according to the invention.03-25-2010